Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868425 · ClinicalTrials.gov registry record · Phase 4
ACL Repair and Multimodal Analgesia
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT01868425 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 112 participants.
The verdict
NCT01868425, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of an aggressive multimodal regimen versus standard multimodal for Anterior Cruciate Ligament (ACL) repair using hamstring graft for patients having surgery in our outpatient surgicenter.
Interventions
- DRUG multimodal:acetaminophen, gabapentin, ketamine, bupivacaine
- DRUG placebo pills and injectables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01868425
The ClinicalTrials.gov registry entry for NCT01868425 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which multimodal:acetaminophen, gabapentin, ketamine, bupivacaine is the first listed.
NCT01868425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01868425 about?
NCT01868425 is a clinical study titled "ACL Repair and Multimodal Analgesia". This study will evaluate the effectiveness of an aggressive multimodal regimen versus standard multimodal for Anterior Cruciate Ligament (ACL) repair using hamstring graft for patients having surgery in our outpatient surgicenter.
What is the current status of trial NCT01868425?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2013-04. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01868425?
The interventions under investigation include: multimodal:acetaminophen, gabapentin, ketamine, bupivacaine (DRUG), placebo pills and injectables (DRUG).
Who is sponsoring clinical trial NCT01868425?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.